The human brain is a complex organ, defined by distinct anatomical regions with unique developmental lineages, cellular compositions, and specliazed functions. Traditional 2D cell cultures cannot fully capture its 3D microenvironment and cellular interactions, while species-specific differences in animal models often limit their translational relevance in studies of brain development, disease mechanisms, and drug responses.
The growing demand for more human-relevant models and more efficient drug development has driven interest in the adoption of New Approach Methodologies (NAMs). Brain organoids are one of theNAM models that recapitulate key features of human brain architecture and cellular composition in vitro, supporting the research of brain development, neurological disorders, drug screening, and safety assessment.
However, theutility of brain organoids depends not only on structural complexity but also on regional specificity and functional relevance. Given the distinct celluar compostions and physiological properties of different brain regions,, selecting an organoid model that aligns with specific research objective is critical for generating biologically relevant and interpretable results.
To support these needs, ACROBiosystems offers ready-to-use iPSC-derived dorsal forebrain organoids, providing a convenient 3D human model to accelerate neuroscience research and drug development.
Conventional brain organoid generation from iPSC involves long-term culture, differentiation, and multiple processing steps, requiring considerable time, specialized expertise, and rigorous experimental control.
ACROBiosystems offers ready-to-use brain organoids developed through standardized differentiation and culture workflows. With a focus on convenience and regional specificity, these models help reduce the time and effort required for in-house model generation significantly.
The current portfolio includes ready-to-use dorsal forebrain organoids and maintenance kits, designed to recapitulate key cortical features of dorsal forebrain and support applications such as studies of brain development, neural function, drug optimization and drug-induced excitotoxicity assessment.
| Cat. No. | Product Description | Product Size |
|---|---|---|
| CIPO-BWL01 | Ready-to-use hiPSC-Derived Dorsal Forebrain Organoids (Standard) | 5 / 20 / 100 organoids |
| CIPO-BWL02 | Ready-to-use hiPSC-Derived Dorsal Forebrain Organoids (Mature) | 5 / 20 / 100 organoids |
| RIPO-BWM01 | hiPSC-Derived Dorsal Forebrain Organoid Maintenance Kit | 60 / 120 / 360 mL |